Severe aortic stenosis affects 1 in 50 Americans over 65, increasing the risk of heart failure and sudden cardiac death. Fortunately, treatment options like Transcatheter Aortic Valve Replacement (TAVR) offer a minimally invasive alternative to open-heart surgery.

TAVR allows cardiologists to replace a diseased aortic valve using a catheter, leading to faster recovery, fewer complications, and improved quality of life.

“TAVR allows us to treat high-risk patients who may not be candidates for open-heart surgery,” says Dr. Ahmed Alabbady, Director of the Structural Heart Program at Good Samaritan Hospital.